Insider Trading History of Sharp Shalini

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Sharp Shalini since 2007. This trader's CIK number is 1377202. At the time of last reporting, Sharp Shalini was the Director of Neurocrine Biosciences Inc. (stock ticker symbol NBIX). Also see all insider trading activities at Neurocrine Biosciences Inc.

Note that in the past Sharp Shalini also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Array Biopharma Inc (ARRY) by Sharp Shalini

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 ARRY 0 $0 0 $0 5,000 $0

Yearly summary of insider trading at Ultragenyx Pharmaceutical Inc. (RARE) by Sharp Shalini

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 RARE 0 $0 56,664 $4,387,665 50,876 $3,132,812
2019 RARE 0 $0 14,800 $1,036,000 43,843 $204,437
2018 RARE 0 $0 26,400 $2,052,095 25,200 $20,537
2017 RARE 0 $0 36,000 $3,004,536 36,000 $29,340
2016 RARE 0 $0 36,000 $2,476,332 42,500 $34,605
2015 RARE 0 $0 43,708 $3,851,894 13,000 $10,595
2014 RARE 4,500 $94,500 20,000 $979,528 0 $0

Yearly summary of insider trading at Nuvation Bio Inc. (NUVB) by Sharp Shalini

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 NUVB 0 $0 0 $0 25,000 $0

Yearly summary of insider trading at Neurocrine Biosciences Inc (NBIX) by Sharp Shalini

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 NBIX 0 $0 0 $0 1,435 $0

Yearly summary of insider trading at Agenus Inc (AGEN) by Sharp Shalini

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 AGEN 0 $0 288 $1,255 0 $0
2012 AGEN 0 $0 576 $2,603 0 $0
2011 AGEN 0 $0 9,994 $21,724 0 $0
2010 AGEN 0 $0 70,818 $61,395 0 $0
2009 AGEN 0 $0 45,796 $76,021 0 $0
2007 AGEN 10,000 $19,570 0 $0 0 $0


Insider trading activities at 5 companies by Sharp Shalini:

1. Array Biopharma Inc (ARRY)

2. Ultragenyx Pharmaceutical Inc. (RARE)

3. Nuvation Bio Inc. (NUVB)

4. Neurocrine Biosciences Inc (NBIX)

5. Agenus Inc (AGEN)

Table 1. Insider trading of Array Biopharma Inc (ARRY) by Sharp Shalini

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-10-26 ARRY Option Ex 5,000 .00 0

Table 2. Insider trading of Ultragenyx Pharmaceutical Inc. (RARE) by Sharp Shalini

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-10-14 RARE Sale 375 87.99 32,996
2020-08-17 RARE Option Ex 11,357 62.18 706,212
2020-08-17 RARE Sale 14,378 88.38 1,270,785
2020-06-04 RARE Sale 2,564 74.01 189,761
2020-06-03 RARE Sale 10,234 74.23 759,669
2020-06-04 RARE Option Ex 2,564 48.43 124,174
2020-06-03 RARE Option Ex 10,234 48.43 495,632
2020-05-19 RARE Sale 7,128 73.32 522,624
2020-05-18 RARE Sale 21,985 73.31 1,611,830
2020-05-19 RARE Option Ex 7,128 59.50 424,116
2020-05-18 RARE Option Ex 19,593 70.57 1,382,678
2019-09-16 RARE Option Ex 31,843 3.83 122,117
2019-03-18 RARE Option Ex 12,000 6.86 82,320
2019-03-18 RARE Sale 14,800 70.00 1,036,000
2018-10-31 RARE Option Ex 12,000 .81 9,780
2018-09-25 RARE Option Ex 3,350 .81 2,730
2018-09-25 RARE Sale 6,700 90.07 603,469
2018-06-07 RARE Option Ex 3,350 .81 2,730
2018-06-07 RARE Sale 6,700 80.07 536,455
2018-05-30 RARE Sale 13,000 70.17 912,171
2018-05-30 RARE Option Ex 6,500 .81 5,297
2017-03-02 RARE Option Ex 12,000 .81 9,780
2017-03-02 RARE Sale 12,000 90.10 1,081,176
2017-02-27 RARE Sale 12,000 80.14 961,680
2017-02-27 RARE Option Ex 12,000 .81 9,780
2017-02-27 RARE Sale 12,000 80.14 961,680
2017-02-27 RARE Option Ex 12,000 .81 9,780
2016-12-23 RARE Option Ex 6,500 .81 5,265
2016-11-09 RARE Option Ex 24,000 .81 19,560
2016-11-09 RARE Sale 24,000 72.51 1,740,192
2016-10-19 RARE Sale 12,000 61.34 736,140
2016-10-19 RARE Option Ex 12,000 .81 9,780
2015-12-10 RARE Sale 12,000 101.59 1,219,140
2015-12-10 RARE Option Ex 12,000 .81 9,780
2015-07-20 RARE Sale 3,854 131.67 507,467
2015-07-20 RARE Sale 3,854 131.67 507,467
2015-06-18 RARE Sale 4,000 96.15 384,600
2015-05-18 RARE Sale 4,000 79.43 317,720
2015-05-01 RARE Option Ex 1,000 .81 815
2015-04-20 RARE Sale 4,000 61.87 247,460
2015-03-18 RARE Sale 4,000 61.45 245,800
2015-02-18 RARE Sale 4,000 54.32 217,284
2015-01-20 RARE Sale 4,000 51.24 204,956
2014-12-18 RARE Sale 4,000 44.82 179,288
2014-11-20 RARE Sale 4,000 44.07 176,280
2014-10-20 RARE Sale 4,000 46.02 184,080
2014-09-18 RARE Sale 4,000 56.00 224,000
2014-08-18 RARE Sale 4,000 53.97 215,880
2014-01-30 RARE Buy 4,500 21.00 94,500

Table 3. Insider trading of Nuvation Bio Inc. (NUVB) by Sharp Shalini

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-02-10 NUVB Option Ex 25,000 .00 0

Table 4. Insider trading of Neurocrine Biosciences Inc (NBIX) by Sharp Shalini

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-05-22 NBIX Option Ex 1,435 .00 0

Table 5. Insider trading of Agenus Inc (AGEN) by Sharp Shalini

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-01-30 AGEN Sale 288 4.36 1,255
2012-10-31 AGEN Sale 288 4.40 1,267
2012-08-29 AGEN Sale 288 4.64 1,336
2011-12-27 AGEN Sale 2,853 2.14 6,105
2011-12-28 AGEN Sale 1,711 2.09 3,575
2011-12-22 AGEN Sale 1,548 2.19 3,390
2011-12-23 AGEN Sale 795 2.20 1,746
2011-12-21 AGEN Sale 3,087 2.24 6,908
2010-10-28 AGEN Sale 1,500 .96 1,440
2010-09-14 AGEN Sale 2,000 .91 1,824
2010-07-27 AGEN Sale 1,520 .93 1,407
2010-04-27 AGEN Sale 1,950 1.16 2,262
2010-01-20 AGEN Sale 63,848 .85 54,462
2009-07-15 AGEN Sale 13,271 1.76 23,396
2009-07-16 AGEN Sale 32,525 1.62 52,625
2007-03-12 AGEN Buy 5,000 1.95 9,735
2007-03-13 AGEN Buy 5,000 1.97 9,835

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sharp Shalini (Director of Neurocrine Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.